[Efficacy and safety of alogliptin in treatment of type 2 diabetes mellitus: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial in mainland China]. (Q51291080)
Jump to navigation
Jump to search
scientific article published in November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | [Efficacy and safety of alogliptin in treatment of type 2 diabetes mellitus: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial in mainland China]. |
scientific article published in November 2015 |
Statements
1 reference
[Efficacy and safety of alogliptin in treatment of type 2 diabetes mellitus: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial in mainland China]. (English)
1 reference
Changyu Pan
1 reference
Wenhui Li
1 reference
Jiaoe Zeng
1 reference
Chengjiang Li
1 reference
Jinkui Yang
1 reference
Qiuhe Ji
1 reference
Juming Lu
1 reference
Xiaofeng Lyu
1 reference
Xuefeng Li
1 reference
Shen Qu
1 reference
Xiangjin Xu
1 reference
Yaoming Xue
1 reference
Ling Li
1 reference
Zhaoshun Jiang
1 reference
Baozhong Zheng
1 reference
Ruifang Bu
1 reference
Ping Han
1 reference
Yu Liu
1 reference
Jingdong Liu
1 reference
Yongde Peng
1 reference
Xiaomin Liu
1 reference
Zhimin Liu
1 reference
Li Yan
1 reference
Minxiang Lei
1 reference
Xuejun Li
1 reference
Qinhua Song
1 reference
Bingyin Shi
1 reference
Wei Gu
1 reference
Zhengfang Li
1 reference
1 November 2015
1 reference
54
1 reference
949-953
1 reference
11
1 reference
Identifiers
1 reference